CopyFind
Nirzolid IV Injection
medicine 📍 IN

Nirzolid IV Injection

210,00 ₹

Analogs of Nirzolid IV Injection

Find cheaper analogs and generic equivalents for Nirzolid IV Injection.

Ingredients

Substancja czynna: Linezolid


Przegląd produktu

About Nirzolid IV Injection

Nirzolid IV Injection is a medication containing the active ingredient Linezolid, classified as Antibiotic medication. Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus….

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Linezolid for Oral Suspension is an oxazolidinone-class antibacterial indicated in adults and children for the treatment of.
  • Used for: Community-acquired pneumonia ( 1
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Linezolid, the active ingredient in Nirzolid IV Injection, belongs to the Antibiotic medication class. 1 INDICATIONS AND USAGE Linezolid for Oral Suspension is an oxazolidinone-class antibacterial indicated in adults and children for the treatment of the following infections caused by susceptible Gram-positive bacteria: Nosocomial pneumonia ( 1. 1 ); Community-acquired pneumonia ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Nirzolid IV Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Nirzolid IV Injection for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Nirzolid IV Injection.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.